CR6086 Uses, Dosage, Side Effects and more

CR6086 is under investigation in clinical trial NCT03163966 (A Study of the EP4 Antagonist CR6086 in Combination With Methotrexate, in Dmard-naïve Patients With Early Rheumatoid Arthritis).

Trade Name CR6086
Generic CR6086
Type
Formula C26H27F3N2O3
Weight Average: 472.508
Monoisotopic: 472.197377226
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share